Intellia Therapeutics

intelliatx.com

Intellia Therapeutics is a pioneering biotechnology company focused on developing potentially curative genome editing treatments using CRISPR technology. The company aims to transform the lives of patients suffering from severe genetic, oncological, and immunological diseases through its innovative therapeutic approaches. With a robust pipeline of clinical programs, Intellia is committed to advancing both in vivo and ex vivo gene editing solutions, leveraging its exclusive access to a comprehensive intellectual property platform. Founded in 2014 and headquartered in Cambridge, Massachusetts, Intellia is positioned as a leader in the CRISPR space, driven by a mission to make transformative therapies a reality for patients in need.